Desq Long
Sign in

Cluster

AGMB-2026-10-05-73c9133f8fbf

SEC FORM 4CLUSTER · 3 INSIDERS
$266,670.00

AgomAb Therapeutics NV (AGMB)

Purchase of 31,000 shares across 3 reporting persons.

Transaction Code P · Reporting Persons 3

  • Epstein David RPurchase of 5,000 shares at $8.57 per share.$42,850.00
  • Epstein David RPurchase of 5,000 shares at $8.7 per share.$43,500.00
  • Kemula Pierre Thadee Victor, Chief Financial OfficerPurchase of 3,000 shares at $8.67 per share.$26,010.00
  • Kemula Pierre Thadee Victor, Chief Financial OfficerPurchase of 5,000 shares at $8.57 per share.$42,850.00
  • Kemula Pierre Thadee Victor, Chief Financial OfficerPurchase of 2,000 shares at $8.54 per share.$17,080.00
  • Knotnerus Tim Jasper, Chief Executive OfficerPurchase of 6,000 shares at $8.48 per share.$50,880.00
  • Knotnerus Tim Jasper, Chief Executive OfficerPurchase of 5,000 shares at $8.7 per share.$43,500.00

Surfaced by rule: 3 distinct insiders, open-market purchases, 7-day window — a deterministic filter, not a recommendation.

Traded Oct 5, 2026 · Disclosed Oct 7, 2026

Source: SEC Form 4 · 0001445826-26-000013 · filed 2026-10-07 · View filing →

Source: SEC Form 4 · 0002119332-26-000001 · filed 2026-10-07 · View filing →

Source: SEC Form 4 · 0002120886-26-000001 · filed 2026-10-07 · View filing →

Permalink →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "AgomAb Therapeutics NV (AGMB)." Disclosed 2026-10-07. https://desqlong.com/cards/cluster-AGMB-2026-10-05-73c9133f8fbf (retrieved 2026-10-08).